Biopharma in Digital Health
- DHV-NET
- Dec 6, 2022
- 1 min read
I. Integration of Digital Health by pharmaceuticals is beginning to gain focus, with the average maturity of new pharmaceutical portfolio ventures in 2022 exceeding the average total portfolio maturity
II. Digital Health solutions for Research and Clinical Trials dominate pharmaceutical portfolios, with 25% of the smallest portfolios (1 to 2 ventures) including ventures in the Research Solutions cluster and 14% including ventures in the Clinical Trials cluster
III. Rankings
